Mechanisms of calcium-induced arrhythmias in arrhythmogenic right ventricular cardiomyopathy
致心律失常性右心室心肌病钙诱导心律失常的机制
基本信息
- 批准号:10346038
- 负责人:
- 金额:$ 38.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAffectAnimalsArrhythmiaArrhythmogenic Right Ventricular DysplasiaBiochemicalCalciumCardiac MyocytesCardiomyopathiesCessation of lifeComplexCrossbreedingCyclic AMP-Dependent Protein KinasesCytosolDataDesmosomesDiseaseDisease ProgressionDislocationsDrug TargetingElectrophysiology (science)EventExhibitsFunctional disorderGenesGeneticGoalsHeartHeart DiseasesHeart failureHereditary DiseaseHomeostasisHumanHyperactivityImageIncidenceInfiltrationIntercalated discIntercellular JunctionsLeadLife ExpectancyLightModelingMolecularMonitorMusMutationMyocardial dysfunctionPatientsPharmaceutical PreparationsPharmacologyPhasePhenotypePhosphorylationPhosphorylation SitePhysiologicalPost-Translational Protein ProcessingPredispositionPreventionProtein Kinase CProteinsPublic HealthRegulationReportingResearchRight ventricular structureRiskRoleRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumSiteSudden DeathTamoxifenTestingThreonineVentricularVentricular Arrhythmiadefined contributiondisease phenotypeefficacy testingheart cellhuman diseaseimaging studyinnovationinsightnovelplakophilin 2preventreceptor functionsudden cardiac deaththerapeutic target
项目摘要
PROJECT SUMMARY / ABSTRACT
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a complex inherited disorder of the heart produced
by mutation in proteins of the desmosome, such as plakophilin-2 (PKP2). Cardiac arrhythmias, and potentially
sudden death, often occur in ARVC patients during the early stages of the disease, a “concealed phase” that
presents before the onset of structural cardiomyopathy. The molecular and cellular mechanisms of these
arrhythmic events remain unclear, hindering the search for effective strategies to treat patients. My long-term
goal is to delineate the mechanisms of arrhythmia in ARVC and to identify potential drug targets to prevent
sudden cardiac death. Mice with tamoxifen (TAM)-induced ablation of PKP2 (PKP2cKO) develop a phenotype
evocative of human ARVC: a concealed stage with high incidence of arrhythmia but without structural remodeling
at 14 days, cardiomyopathy of right ventricle dominance at 21 days, and biventricular cardiomyopathy, heart
failure and death at ~42 days post-TAM. We reported that PKP2cKO hearts show significant dysregulation of
Ca2+ handling at different stages of disease progression but, most remarkably, during the concealed stage of the
disease. This proposal aims to elucidate the mechanisms underlying cardiac arrhythmia in PKP2-deficient hearts
focusing on the microdomain where Ca2+ regulation takes place. I hypothesize that dysfunction of the cardiac
ryanodine receptor (RyR2), a major intracellular Ca2+ release channel, and the ensuing Ca2+ mishandling are
critical triggers of cardiac arrhythmia in the PKP2cKO mouse and, hence, in ARVC. These aims will test my
hypothesis: 1) Determine the role of protein kinase C (PKC) phosphorylation in the regulation of RyR2 channel
function and calcium homeostasis. Preliminary data suggest that RyR2 is undergoing phosphorylation in
PKP2cKO hearts at Thr2810. This previously uncharacterized site is a predicted PKC substrate. I hypothesize
that PKC phosphorylation of RyR2 at Thr2810 regulates channel function and contributes to arrhythmogenic
Ca2+ release in the diseased heart. 2) Define the contribution of RyR2 dysfunction in the onset and progression
of heart disease in PKP2cKO mice. Preliminary data suggest that RyR2 phosphorylation at Thr2810 and Ser2030
is increased in ARVC. I hypothesize that inhibition of RyR2 phosphorylation at these sites prevents arrhythmia
and sudden death in PKP2cKO mice. 3) Test the efficacy of RyR2 modulators for the prevention of arrhythmia
in PKP2-deficient hearts. I hypothesize that pharmacological modulation of RyR2 is beneficial to prevent
arrhythmia in PKP2cKO mice and hearts. The completion of these aims will provide significant insight into the
regulation of RyR2 function in a model of PKP2cKO deficiency and hence shed light on the mechanisms
underlying ARVC. I anticipate these results will advance the status of RyR2 as a potential therapeutic target to
reduce the risk of arrhythmias and increase life-expectancy of patients with ARVC.
项目摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Francisco J Alvarado其他文献
Francisco J Alvarado的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Francisco J Alvarado', 18)}}的其他基金
2023 Muscle: Excitation-Contraction Coupling Gordon Research Conference and Gordon Research Seminar
2023肌肉:兴奋-收缩耦合戈登研究会议暨戈登研究研讨会
- 批准号:
10606049 - 财政年份:2023
- 资助金额:
$ 38.88万 - 项目类别:
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias
RyR 激动剂部分且受控地消耗 SR 钙可预防钙依赖性心律失常
- 批准号:
10577630 - 财政年份:2023
- 资助金额:
$ 38.88万 - 项目类别:
Mechanisms of calcium-induced arrhythmias in arrhythmogenic right ventricular cardiomyopathy
致心律失常性右室心肌病钙诱导心律失常的机制
- 批准号:
10539305 - 财政年份:2022
- 资助金额:
$ 38.88万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 38.88万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 38.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 38.88万 - 项目类别:
Studentship